Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of three compounds (viability/apoptosis dataset 2 of 2) - Dataset (ID:20273)

Filter results: >>>>
Cell Small Molecule 1 Small Molecule 2 Small Molecule 3 Small Mol 1 Concentration Small Mol 2 Concentration Small Mol 3 Concentration Small Mol Conc Unit Time Point Time Point Unit Replicate Total Number of Cells (Nuclei) Number of Apoptotic Cells Relative Viability Mean Relative Viability Apoptosis Fraction Mean Apoptosis Fraction
COLO 858 Vemurafenib Trametinib Belinostat 1.0000 0.1000 0.0000
uM
72
hr
2 1012 727 0.0618 0.0606 0.7184 0.7233
COLO 858 Vemurafenib Trametinib Belinostat 1.0000 0.1000 0.0000
uM
72
hr
3 1235 937 0.0646 0.0606 0.7587 0.7233
COLO 858 Vemurafenib Trametinib Belinostat 1.0000 0.1000 1.0000
uM
72
hr
1 939 641 0.0646 0.0538 0.6826 0.7062
COLO 858 Vemurafenib Trametinib Belinostat 1.0000 0.1000 1.0000
uM
72
hr
2 803 555 0.0538 0.0538 0.6912 0.7062
COLO 858 Vemurafenib Trametinib Belinostat 1.0000 0.1000 1.0000
uM
72
hr
3 776 578 0.0429 0.0538 0.7448 0.7062
COLO 858 Vemurafenib Trametinib Belinostat 3.1600 0.3160 0.0000
uM
72
hr
1 617 518 0.0215 0.0184 0.8395 0.8831
COLO 858 Vemurafenib Trametinib Belinostat 3.1600 0.3160 0.0000
uM
72
hr
2 797 720 0.0167 0.0184 0.9034 0.8831
COLO 858 Vemurafenib Trametinib Belinostat 3.1600 0.3160 0.0000
uM
72
hr
3 843 764 0.0171 0.0184 0.9063 0.8831
COLO 858 Vemurafenib Trametinib Belinostat 3.1600 0.3160 1.0000
uM
72
hr
1 716 498 0.0473 0.0457 0.6955 0.6841
COLO 858 Vemurafenib Trametinib Belinostat 3.1600 0.3160 1.0000
uM
72
hr
2 654 466 0.0408 0.0457 0.7125 0.6841